TFTyler Funnell

Tyler Funnell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tyler Funnell has a total of 288 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sugar-rich foods exacerbate antibiotic-induced microbiome disruption

    by Anqi Dai, Annamaria Ballweg, William Jogia, Madhumitha Rangesa, Peter A. Adintori, Mirae Baichoo, Tyler Funnell, Teng Fei, Nicholas R. Waters, Abrielle Swartz, et al.

    Diet shapes the composition of the gut microbiota1; however, the specific effects of distinct food groups on microbiome dynamics are unclear, particularly in circumstances of extreme perturbation. Here we evaluated the relationship between diet and intestinal microbiome dynamics by precisely tracking 9,419 meals consumed by 173 patients who were hospitalized for haematopoietic cell transplantation and analysing subsequent microbiome changes. Bayesian inference applied to data from 158 patients with paired longitudinal microbiome samples revealed that the intake of sweets and sugars during antibiotic exposure predicted exacerbated microbial dysbiosis, manifesting as lowered α-diversity and greater expansion of the pathobiont Enterococcus. Experiments in mice also showed that sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion. These data suggest that avoiding a diet rich in simple sugars during antibiotic treatment may mitigate microbiota disruption. Further studies in independent cohorts will offer opportunities to generalize these findings and evaluate microbiota-sparing interventions.


  • Open Access

    Damage and Misrepair Signatures: Compact Representations of Pan-cancer Mutational Processes

    by Caitlin F. Harrigan, Kieran R. Campbell, Quaid Morris, Tyler Funnell

    Mutational signatures of single-base substitutions (SBSs) characterize somatic mutation processes which contribute to cancer development and progression. However, current mutational signatures do not distinguish the two independent steps that generate SBSs: the initial DNA damage followed by erroneous repair. To address this modelling gap we developed DAMUTA, a hierarchical Bayesian probabilistic model that infers separate signatures for each process, and captures their sample-specific interaction. We applied DAMUTA to 18,974 pan-cancer whole genome sequencing mutation catalogues from 23 cancer types and show that tissue-specificity in mutation patterns is driven largely by variability in damage processes. We also show that misrepair processes are predictive of DNA damage response deficiencies. Unlike existing approaches, DAMUTA distinguishes damage from misrepair contributions, and we demonstrate significant improvements over a mutational-burden baseline or signatures from the COSMIC database. Our analysis reveals a shared pan-cancer pattern of early clonal transition-mutations which shifts to a more uniform substitution pattern consistent with increased reliance on translesion synthesis for damage tolerance. DAMUTA thus generates a compact set of signatures which resolves redundancies of current signature models, disentangles the effects of DNA damage and misrepair processes, and facilitates improved stratification of tumours, while providing a framework towards a unified pan-cancer model of the cellular response to DNA damage.

  • Top Cited Papers
    Open Access

    An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma

    by Sandeep S. Raj, Teng Fei, Shalev Fried, Andrew Ip, Joshua A. Fein, Lori A. Leslie, Ana Alarcon Tomas, Doris Leithner, Jonathan U. Peled, Magdalena Corona, et al.

    Disease progression is a substantial challenge in patients with non-Hodgkin lymphoma (NHL) undergoing chimeric antigen receptor T cell (CAR-T) therapy. Here we present InflaMix (INFLAmmation MIXture Model), an unsupervised quantitative model integrating 14 pre-CAR-T infusion laboratory and cytokine measures capturing inflammation and end-organ function. Developed using a cohort of 149 patients with NHL, InflaMix revealed an inflammatory signature associated with a high risk of CAR-T treatment failure, including increased hazard of death or relapse (hazard ratio, 2.98; 95% confidence interval, 1.60–4.91; P < 0.001). Three independent cohorts comprising 688 patients with NHL from diverse treatment centers were used to validate our approach. InflaMix consistently and reproducibly identified patients with a higher likelihood of disease relapse and mortality, and it provided supplementary predictive value beyond established prognostic markers, including tumor burden. Moreover, InflaMix exhibited robust performance in cases with missing data, maintaining accuracy when considering only six readily available laboratory measures. These findings show that InflaMix is a valuable tool for point-of-care clinical decision-making in patients with NHL undergoing CAR-T therapy.


  • Open Access

    Correlating High-dimensional longitudinal microbial features with time-varying outcomes with FLORAL

    by Teng Fei, Victoria Donovan, Tyler Funnell, Mirae Baichoo, Nicholas R. Waters, Jenny Paredes, Anqi Dai, Francesca Castro, Jennifer Haber, Ana Gradissimo, et al.

    Correlating time-dependent patient characteristics and matched microbiome samples can identify biomarkers in longitudinal microbiome studies. Existing approaches typically repeat a pre-specified modeling approach for all taxonomic features, followed by a multiple testing adjustment step for false discovery rate (FDR) control. In this work, we develop an alternative strategy of using log-ratio penalized generalized estimating equations, which directly models the longitudinal patient characteristic of interest as the outcome variable and treats microbial features as high-dimensional compositional covariates. A cross validation procedure is developed for variable selection and model selection among different working correlation structures. In extensive simulations, the proposed method achieved superior sensitivity over the state-of-the-art methods with robustly controlled FDR. In the analyses of correlating longitudinal dietary intake, bloodstream infection status, and microbial features from matched samples of cancer patients, the proposed method effectively identified gut health indicators and clinically relevant microbial markers, showing robust utilities in real-world applications. The method is implemented under the open-source R package FLORAL , which is available at ( https://vdblab.github.io/FLORAL/ ).


  • Open Access

    Sugar-rich foods exacerbate antibiotic-induced microbiome injury

    by Anqi Dai, Peter A Adintori, Tyler Funnell, William P Jogia, Teng Fei, Nicholas R Waters, Madhumitha Rangesa, Annamaria Ballweg, Brianna Gipson, Sandeep Raj, et al.

    Intestinal microbiota composition is implicated in several diseases; understanding the factors that influence it are key to elucidating host-commensal interactions and to designing microbiome-targeted therapies. We quantified how diet influences microbiome dynamics in hospitalized patients. We recorded 9,419 meals consumed by 173 patients undergoing hematopoietic cell transplantation and profiled the microbiome in 1,009 longitudinally collected stool samples from 158 of them. Caloric intake was correlated with fecal microbiota diversity. Bayesian inference revealed associations between intake of sweets or sugars during antibiotic exposure with microbiome disruption, as assessed by low diversity or expansion of the pathobiont Enterococcus. We validated this observation experimentally, finding that sucrose exacerbated antibiotic-induced Enterococcus expansion in mice. Taken together, our results suggest that avoiding sugar-rich foods during antibiotic treatment may reduce microbiome injury.


  • Open Access

    Single-cell mtDNA dynamics in tumors is driven by coregulation of nuclear and mitochondrial genomes

    by Minsoo Kim, Alexander N. Gorelick, Ignacio Vàzquez-García, Marc J. Williams, Sohrab Salehi, Hongyu Shi, Adam C. Weiner, Nick Ceglia, Tyler Funnell, Tricia Park, et al.

    The extent of cell-to-cell variation in tumor mitochondrial DNA (mtDNA) copy number and genotype, and the phenotypic and evolutionary consequences of such variation, are poorly characterized. Here we use amplification-free single-cell whole-genome sequencing (Direct Library Prep (DLP+)) to simultaneously assay mtDNA copy number and nuclear DNA (nuDNA) in 72,275 single cells derived from immortalized cell lines, patient-derived xenografts and primary human tumors. Cells typically contained thousands of mtDNA copies, but variation in mtDNA copy number was extensive and strongly associated with cell size. Pervasive whole-genome doubling events in nuDNA associated with stoichiometrically balanced adaptations in mtDNA copy number, implying that mtDNA-to-nuDNA ratio, rather than mtDNA copy number itself, mediated downstream phenotypes. Finally, multimodal analysis of DLP+ and single-cell RNA sequencing identified both somatic loss-of-function and germline noncoding variants in mtDNA linked to heteroplasmy-dependent changes in mtDNA copy number and mitochondrial transcription, revealing phenotypic adaptations to disrupted nuclear/mitochondrial balance.


  • FLORAL: Fit Log-Ratio Lasso Regression for Compositional Data

    by Teng Fei, Tyler Funnell, Nicholas Waters, Sandeep Raj

  • Open Access

    Enhanced Feature Selection for Microbiome Data using FLORAL: Scalable Log-ratio Lasso Regression

    by Teng Fei, Tyler Funnell, Nicholas R. Waters, Sandeep S. Raj, Keimya Sadeghi, Anqi Dai, Oriana Miltiadous, Roni Shouval, Meng Lv, Jonathan U. Peled, et al.

    Identifying predictive biomarkers of patient outcomes from high-throughput microbiome data is of high interest in contemporary cancer research. We present FLORAL, an open-source computational tool to perform scalable log-ratio lasso regression modeling and microbial feature selection for continuous, binary, time-to-event, and competing risk outcomes. The proposed method adapts the augmented Lagrangian algorithm for a zero-sum constraint optimization problem while enabling a two-stage screening process for extended false-positive control. In extensive simulation studies, FLORAL achieved consistently better false-positive control compared to other lasso-based approaches and better variable selection F1 score over popular differential abundance approaches. We demonstrate the practical utility of the proposed tool with a real data application on an allogeneic hematopoietic-cell transplantation cohort. The R package is available at https://github.com/vdblab/FLORAL.


  • Top Cited Papers
    Open Access

    Ovarian cancer mutational processes drive site-specific immune evasion

    by Ignacio Vázquez-García, Florian Uhlitz, Nicholas Ceglia, Jamie L. P. Lim, Michelle Wu, Neeman Mohibullah, Juliana Niyazov, Arvin Eric B. Ruiz, Kevin M. Boehm, Viktoria Bojilova, et al.

    High-grade serous ovarian cancer (HGSOC) is an archetypal cancer of genomic instability1–4 patterned by distinct mutational processes5,6, tumour heterogeneity7–9 and intraperitoneal spread7,8,10. Immunotherapies have had limited efficacy in HGSOC11–13, highlighting an unmet need to assess how mutational processes and the anatomical sites of tumour foci determine the immunological states of the tumour microenvironment. Here we carried out an integrative analysis of whole-genome sequencing, single-cell RNA sequencing, digital histopathology and multiplexed immunofluorescence of 160 tumour sites from 42 treatment-naive patients with HGSOC. Homologous recombination-deficient HRD-Dup (BRCA1 mutant-like) and HRD-Del (BRCA2 mutant-like) tumours harboured inflammatory signalling and ongoing immunoediting, reflected in loss of HLA diversity and tumour infiltration with highly differentiated dysfunctional CD8+ T cells. By contrast, foldback-inversion-bearing tumours exhibited elevated immunosuppressive TGFβ signalling and immune exclusion, with predominantly naive/stem-like and memory T cells. Phenotypic state associations were specific to anatomical sites, highlighting compositional, topological and functional differences between adnexal tumours and distal peritoneal foci. Our findings implicate anatomical sites and mutational processes as determinants of evolutionary phenotypic divergence and immune resistance mechanisms in HGSOC. Our study provides a multi-omic cellular phenotype data substrate from which to develop and interpret future personalized immunotherapeutic approaches and early detection research.


  • Open Access

    Single-cell genomic variation induced by mutational processes in cancer

    by Tyler Funnell, Ciara H. O’flanagan, Marc J. Williams, Andrew McPherson, Steven McKinney, Farhia Kabeer, Hakwoo Lee, Sohrab Salehi, Ignacio Vázquez-García, Hongyu Shi, et al.

    How cell-to-cell copy number alterations that underpin genomic instability1in human cancers drive genomic and phenotypic variation, and consequently the evolution of cancer2, remains understudied. Here, by applying scaled single-cell whole-genome sequencing3to wild-type,TP53-deficient andTP53-deficient;BRCA1-deficient orTP53-deficient;BRCA2-deficient mammary epithelial cells (13,818 genomes), and to primary triple-negative breast cancer (TNBC) and high-grade serous ovarian cancer (HGSC) cells (22,057 genomes), we identify three distinct ‘foreground’ mutational patterns that are defined by cell-to-cell structural variation. Cell- and clone-specific high-level amplifications, parallel haplotype-specific copy number alterations and copy number segment length variation (serrate structural variations) had measurable phenotypic and evolutionary consequences. In TNBC and HGSC, clone-specific high-level amplifications in known oncogenes were highly prevalent in tumours bearing fold-back inversions, relative to tumours with homologous recombination deficiency, and were associated with increased clone-to-clone phenotypic variation. Parallel haplotype-specific alterations were also commonly observed, leading to phylogenetic evolutionary diversity and clone-specific mono-allelic expression. Serrate variants were increased in tumours with fold-back inversions and were highly correlated with increased genomic diversity of cellular populations. Together, our findings show that cell-to-cell structural variation contributes to the origins of phenotypic and evolutionary diversity in TNBC and HGSC, and provide insight into the genomic and mutational states of individual cancer cells.